Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 6, 2022; 10(19): 6587-6594
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Published online Jul 6, 2022. doi: 10.12998/wjcc.v10.i19.6587
Figure 2 Dynamic changes of hemoglobin and serum ferritin.
The patient was admitted to our hospital on July 24, 2020. He was treated with 1.5 units of red blood cell transfusion on that day. After discharge, he began to take 20 mg oral roxadustat three times a week on August 1, 2020. Then he began to take 50 mg oral roxadustat three times a week on December 8, 2020. Hb: Hemoglobin; SF: Serum ferritin.
- Citation: Zhou QQ, Li J, Liu B, Wang CL. Roxadustat for treatment of anemia in a cancer patient with end-stage renal disease: A case report. World J Clin Cases 2022; 10(19): 6587-6594
- URL: https://www.wjgnet.com/2307-8960/full/v10/i19/6587.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i19.6587